Application 020500

Type
NDA
Sponsor
GLAXOSMITHKLINE LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MEPRONATOVAQUONESUSPENSION;ORAL750MG/5MLYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020500-001MEPRONATOVAQUONE750MG/5MLSUSPENSION / ORALABRLD, RS1995-02-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N020500-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N020500-001MEPRON750MG/5MLSUSPENSION / ORALABRLD, RS1995-02-08a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N020500-001AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEPRONATOVAQUONEGlaxoSmithKline LLCb426b6bf-f07e-4580-97ae-dfca1ddf5b8f2026-03-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 020500
application number: NDA020500
ndc (product): 0173-0547
ndc (product): 0173-0665

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 15 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0547MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
0173-0665MEPRONatovaquoneGlaxoSmithKline LLCNDACurrent
66993-062AtovaquoneatovaquonePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-062AtovaquoneatovaquonePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent
66993-062AtovaquoneatovaquonePrasco LaboratoriesNDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85637SUPPL 2026-04-06
85442SUPPL 2026-03-23
59384SUPPL2019-07-19
59378SUPPL2019-07-19
57879SUPPL2019-03-04
57816SUPPL2019-02-27
50087SUPPL2017-10-18
50070SUPPL2017-10-17
12644SUPPL2015-06-10
2608SUPPL2015-06-10
12643SUPPL2013-03-05
25055SUPPL2013-03-04
34717SUPPL2008-05-12
2607SUPPL2008-05-09
41397SUPPL2004-06-09
25054SUPPL2004-06-09
12642SUPPL2004-06-09